Results 21 to 30 of about 3,438,764 (296)

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

Prevalence and associations of asteroid hyalosis: the Beijing Eye Study

open access: yesBMC Ophthalmology, 2022
Background To determine the prevalence and associations of asteroid hyalosis (AH) in a Chinese population-based cohort. Methods The retrospective, cross-sectional, population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 ±
Chuan Zhang   +5 more
doaj   +1 more source

Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning

open access: yesFrontiers in Medicine, 2022
IntroductionUveal melanoma (UM) is the most common intraocular malignancy in adults. Plaque brachytherapy remains the dominant eyeball-conserving therapy for UM. Tumor regression in UM after plaque brachytherapy has been reported as a valuable prognostic
Jingting Luo   +9 more
doaj   +1 more source

Characteristic and Correlation Between TIME and Complication After Destructive Eye Procedure Patient at Plastic and Reconstruction Division Sanglah Hospital\u27s Eye Clinic Bali-Indonesia [PDF]

open access: yes, 2012
Destructive eye procedure can be carried out by enucleation, evisceration and excenteration. Some efforts have been developed to reduce the complications, but it still occur within several years after the operation.
Sukartini, D. (D)   +2 more
core   +2 more sources

Screening for novel risk factors related to high myopia using machine learning

open access: yesBMC Ophthalmology, 2022
Background High myopia-related complications have become a major cause of irreversible vision loss. Evaluating the association between potential factors and high myopia can provide insights into pathophysiologic mechanisms and further intervention ...
Ruiheng Zhang   +7 more
doaj   +1 more source

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future [PDF]

open access: yes, 2019
Ocular diseases cause visual impairment and blindness, imposing a devastating impact on quality of life and a substantial societal economic burden. Many such diseases lack universally effective pharmacotherapies.
Corson, Timothy W., Park, Bomina
core   +1 more source

Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection

open access: yesInvestigative Ophthalmology and Visual Science, 2016
Purpose Immune privilege of the eye protects the nonregenerative ocular tissues from innate and adaptive immune-mediated inflammation. In the case of intraocular tumors, immune privilege can be arrested to allow for immune-mediated rejection.
Ann J. Ligocki, J. Niederkorn
semanticscholar   +1 more source

Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy

open access: yesBMC Ophthalmology, 2022
Background Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Plaque brachytherapy (PRT) is widely accepted as an effective globe-conserving treatment modality for UM.
Heng Wang   +6 more
doaj   +1 more source

Prophylactic interventions for preventing macular edema after cataract surgery in patients with diabetes: A Bayesian network meta-analysis of randomized controlled trials

open access: yesEClinicalMedicine, 2022
Summary: Background: Diabetes significantly increases the risk of postoperative macular edema (PME) after cataract surgery, leading to potential worst post-operative outcomes. This study aims to compare the effect of different prophylactic interventions
Ruiheng Zhang   +10 more
doaj   +1 more source

In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Uveal melanoma (UM) is the most frequent intraocular malignancy and is resistant to immunotherapy. Nearly 50% of patients with UM develop metastatic disease, and the overall survival outcome remains very poor.
Seohyun Kim   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy